Boston Scientific CorporationBSXNYSE
Loading
EPS Diluted Over TimeExpanding
Percentile Rank93
3Y CAGR+63.3%
Year-over-Year Change
Diluted earnings per share
3Y CAGR
+63.3%/yr
vs -21.8%/yr prior
Acceleration
+85.0pp
Accelerating
Percentile
P93
Near historical high
vs 3Y Ago
4.4x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.94 | +55.2% |
| 2024 | 1.25 | +16.5% |
| 2023 | 1.07 | +140.6% |
| 2022 | 0.45 | -35.1% |
| 2021 | 0.69 | +946.1% |
| 2020 | -0.08 | -102.4% |
| 2019 | 3.33 | +180.0% |
| 2018 | 1.19 | +1493.0% |
| 2017 | 0.07 | -70.1% |
| 2016 | 0.25 | - |